Legal & General Group
AURA icon

Legal & General Group’s Aura Biosciences AURA Stock Holding History

Legal & General Group’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.4K Sell
4,096
-246
-6% -$1.41K ﹤0.01% 2860
2025
Q4 		$23.7K Hold
4,342
– – ﹤0.01% 2960
2025
Q3 		$26.8K Buy
4,342
+656
+18% +$4.29K ﹤0.01% 2926
2025
Q2 		$23.1K Sell
3,686
-325
-8% -$1.9K ﹤0.01% 2952
2025
Q1 		$23.5K Hold
4,011
– – ﹤0.01% 2891
2024
Q4 		$33K Hold
4,011
– – ﹤0.01% 2862
2024
Q3 		$35.7K Hold
4,011
– – ﹤0.01% 2849
2024
Q2 		$30.3K Buy
4,011
+1,121
+39% +$8.21K ﹤0.01% 2876
2024
Q1 		$22.7K Buy
2,890
+568
+24% +$4.71K ﹤0.01% 2916
2023
Q4 		$20.6K Hold
2,322
– – ﹤0.01% 3025
2023
Q3 		$20.8K Sell
2,322
-319
-12% -$3.43K ﹤0.01% 3007
2023
Q2 		$32.6K Sell
2,641
-210
-7% -$2.25K ﹤0.01% 2944
2023
Q1 		$26.5K Buy
2,851
+595
+26% +$6.18K ﹤0.01% 2994
2022
Q4 		$23.7K Hold
2,256
– – ﹤0.01% 3116
2022
Q3 		$41K Buy
2,256
+1,394
+162% +$21.1K ﹤0.01% 3017
2022
Q2 		$12K Buy
862
+360
+72% +$5.96K ﹤0.01% 3345
2022
Q1 		$11K Hold
502
– – ﹤0.01% 3378
2021
Q4 		$8K Buy
+502
New +$8.97K ﹤0.01% 3490

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Legal & General Group's AURA Position: Q1 2026 in Review

Legal & General Group reduced its Aura Biosciences (AURA) stake by 5.7% in Q1 2026, selling an estimated $1.41K and leaving 4,096 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

Legal & General Group first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $41K in Q3 2022. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Legal & General Group held 4,096 shares of Aura Biosciences worth $27.4K as of Q1 2026.
  • Legal & General Group sold 246 Aura Biosciences shares in Q1 2026, an estimated $1.41K.
  • Aura Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2860 holding.
  • Legal & General Group first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Legal & General Group's Aura Biosciences position peaked at $41K in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.